Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A combined immunodeficiency syndrome in which the cause of the disease is a variation in the IKZF2 gene.
Biomarker and diagnostic research for IKZF2-related combined immunodeficiency has been reported in the published literature.
No clinical trials have been registered for IKZF2-related combined immunodeficiency.
276 publications have been identified in PubMed for IKZF2-related combined immunodeficiency. Research spans Review / Meta-Analysis (27%), Basic Science / Preclinical (19%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 75 | 27% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 7:51 AM UTC
Common questions about IKZF2-related combined immunodeficiency
Laboratory research
53 |
19% |
Patient case studies | 47 | 17% |
Disease patterns and progression | 38 | 14% |
Clinical study results | 23 | 8% |
Testing and diagnosis research | 20 | 7% |
New treatment approaches | 17 | 6% |
Other research | 3 | 1% |
Chirila CB (2026). [PMID: 42002600](https://pubmed.ncbi.nlm.nih.gov/42002600/). *Sci Rep*. [Gene Therapy / Novel Therapeutics]
Bressan V (2026). [PMID: 42155336](https://pubmed.ncbi.nlm.nih.gov/42155336/). *Patient Educ Couns*. [Review / Meta-Analysis]
Singh VK (2026). [PMID: 41883165](https://pubmed.ncbi.nlm.nih.gov/41883165/). *Mol Ther*. [Basic Science / Preclinical]
Laberko A (2026). [PMID: 41786511](https://pubmed.ncbi.nlm.nih.gov/41786511/). *Expert Rev Clin Immunol*. [Review / Meta-Analysis]
Fliegauf M (2026). [PMID: 41202999](https://pubmed.ncbi.nlm.nih.gov/41202999/). *Clin Immunol*. [Basic Science / Preclinical]
Wiscovitch-Russo R (2026). [PMID: 41544031](https://pubmed.ncbi.nlm.nih.gov/41544031/). *PLoS One*. [Basic Science / Preclinical]
Soomann M (2026). [PMID: 41177434](https://pubmed.ncbi.nlm.nih.gov/41177434/). *The journal of allergy and clinical immunology. In practice*. [Epidemiology / Natural History]
Yue J (2026). [PMID: 41147740](https://pubmed.ncbi.nlm.nih.gov/41147740/). *Arthritis Rheumatol*. [Diagnostic / Biomarker]
Martinez T (2026). [PMID: 41980333](https://pubmed.ncbi.nlm.nih.gov/41980333/). *Curr Opin Immunol*. [Review / Meta-Analysis]
Jacovas VC (2026). [PMID: 41104538](https://pubmed.ncbi.nlm.nih.gov/41104538/). *Genetics in medicine : official journal of the American College of Medical Genetics*. [Diagnostic / Biomarker]